Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 2 (2005), Issue 11 (November)

1. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.
   Hepatology, 42(5): 1194-202. [Abstract] [Full-text]
2. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
   Hepatology, 42(5): 1184-93. [Abstract] [Full-text]
3. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.
   Hepatology, 42(5): 1158-65. [Abstract] [Full-text]
4. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis.
   Am J Gastroenterol, 100(11): 2438-46. [Abstract] [Full-text]
5. Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis.
   Gut, 54(12): 1668-71. [Abstract] [Full-text]
6. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.
   Gut, 54(12): 1790-6. [Abstract] [Full-text]
7. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
   N Engl J Med, 353(21): 2254-61. [Abstract] [Full-text]
8. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.
   J Lab Clin Med, 146(6): 347-51. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.